MassBio Releases Five-Year Plan for Future Direction of Massachusetts Life Sciences Ecosystem
The Massachusetts Biotechnology Council (MassBio) today released its State of Possible 2025 Report, a five-year strategic plan to define the future direction of the Massachusetts life sciences ecosystem and highlight the many systemic challenges that require attention for the cluster to stay ahead of the curve on scientific innovation. The report will also serve as a call to action to drive cross-industry collaboration in order to overcome shared challenges, capitalize on Massachusetts’ greatest assets, and develop strategic economic development.
Through interviews and consultations with government, academic, and industry leaders, this report, prepared by Deloitte, found that the Massachusetts life sciences community is expected to achieve balanced growth over the next five years. Some of the areas include expanding R&D beyond oncology and rare diseases as well as positioning the state as a center for medical technology.
The report also calls attention to some gaps for improvement needed for the industry to thrive and grow sustainably. Some of these gaps are the availability of funding and the lack of affordable space and an efficient transportation system.
For more information on the full report, click here.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
